nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00212	0.00293	CcSEcCtD
Levorphanol—Vomiting—Nateglinide—type 2 diabetes mellitus	0.0021	0.00291	CcSEcCtD
Levorphanol—Rash—Nateglinide—type 2 diabetes mellitus	0.00209	0.00288	CcSEcCtD
Levorphanol—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.00209	0.00288	CcSEcCtD
Levorphanol—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00208	0.00288	CcSEcCtD
Levorphanol—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00207	0.00286	CcSEcCtD
Levorphanol—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.00206	0.00285	CcSEcCtD
Levorphanol—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.00205	0.00284	CcSEcCtD
Levorphanol—Nausea—Acarbose—type 2 diabetes mellitus	0.00204	0.00282	CcSEcCtD
Levorphanol—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00204	0.00281	CcSEcCtD
Levorphanol—Constipation—Glipizide—type 2 diabetes mellitus	0.00203	0.0028	CcSEcCtD
Levorphanol—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00203	0.0028	CcSEcCtD
Levorphanol—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00201	0.00278	CcSEcCtD
Levorphanol—Insomnia—Glimepiride—type 2 diabetes mellitus	0.002	0.00276	CcSEcCtD
Levorphanol—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.00199	0.00276	CcSEcCtD
Levorphanol—Renal failure—Irbesartan—type 2 diabetes mellitus	0.00199	0.00275	CcSEcCtD
Levorphanol—Estrone—SHBG—type 2 diabetes mellitus	0.00199	0.121	CrCbGaD
Levorphanol—Tension—Gliclazide—type 2 diabetes mellitus	0.00197	0.00272	CcSEcCtD
Levorphanol—Nausea—Nateglinide—type 2 diabetes mellitus	0.00197	0.00272	CcSEcCtD
Levorphanol—Bradycardia—Metformin—type 2 diabetes mellitus	0.00196	0.00271	CcSEcCtD
Levorphanol—Shock—Bromocriptine—type 2 diabetes mellitus	0.00196	0.00271	CcSEcCtD
Levorphanol—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00195	0.0027	CcSEcCtD
Levorphanol—Nervousness—Gliclazide—type 2 diabetes mellitus	0.00195	0.00269	CcSEcCtD
Levorphanol—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00195	0.00269	CcSEcCtD
Levorphanol—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.00195	0.00269	CcSEcCtD
Levorphanol—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.00194	0.00268	CcSEcCtD
Levorphanol—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00194	0.00268	CcSEcCtD
Levorphanol—Convulsion—Glyburide—type 2 diabetes mellitus	0.00194	0.00268	CcSEcCtD
Levorphanol—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00192	0.00265	CcSEcCtD
Levorphanol—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00189	0.00261	CcSEcCtD
Levorphanol—Urticaria—Glipizide—type 2 diabetes mellitus	0.00188	0.0026	CcSEcCtD
Levorphanol—Renal failure—Losartan—type 2 diabetes mellitus	0.00188	0.00259	CcSEcCtD
Levorphanol—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00187	0.00259	CcSEcCtD
Levorphanol—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00187	0.00259	CcSEcCtD
Levorphanol—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00186	0.00258	CcSEcCtD
Levorphanol—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00185	0.00256	CcSEcCtD
Levorphanol—Agitation—Gliclazide—type 2 diabetes mellitus	0.00184	0.00255	CcSEcCtD
Levorphanol—Confusional state—Glyburide—type 2 diabetes mellitus	0.00184	0.00254	CcSEcCtD
Levorphanol—Sweating—Losartan—type 2 diabetes mellitus	0.00183	0.00253	CcSEcCtD
Levorphanol—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00182	0.00252	CcSEcCtD
Levorphanol—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00182	0.00252	CcSEcCtD
Levorphanol—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00182	0.00251	CcSEcCtD
Levorphanol—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00181	0.0025	CcSEcCtD
Levorphanol—Rash—Repaglinide—type 2 diabetes mellitus	0.00181	0.0025	CcSEcCtD
Levorphanol—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.0018	0.00249	CcSEcCtD
Levorphanol—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.0018	0.00249	CcSEcCtD
Levorphanol—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.0018	0.00249	CcSEcCtD
Levorphanol—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.0018	0.00249	CcSEcCtD
Levorphanol—Shock—Glyburide—type 2 diabetes mellitus	0.00179	0.00248	CcSEcCtD
Levorphanol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00179	0.00247	CcSEcCtD
Levorphanol—Flushing—Metformin—type 2 diabetes mellitus	0.00179	0.00247	CcSEcCtD
Levorphanol—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00177	0.00245	CcSEcCtD
Levorphanol—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.00177	0.00245	CcSEcCtD
Levorphanol—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.00176	0.00244	CcSEcCtD
Levorphanol—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00176	0.00243	CcSEcCtD
Levorphanol—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00176	0.00243	CcSEcCtD
Levorphanol—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.00175	0.00242	CcSEcCtD
Levorphanol—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.00175	0.00242	CcSEcCtD
Levorphanol—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00175	0.00242	CcSEcCtD
Levorphanol—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00175	0.00242	CcSEcCtD
Levorphanol—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00174	0.00241	CcSEcCtD
Levorphanol—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00174	0.0024	CcSEcCtD
Levorphanol—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00171	0.00236	CcSEcCtD
Levorphanol—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00171	0.00236	CcSEcCtD
Levorphanol—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00171	0.00236	CcSEcCtD
Levorphanol—Hypotension—Glyburide—type 2 diabetes mellitus	0.0017	0.00236	CcSEcCtD
Levorphanol—Nausea—Repaglinide—type 2 diabetes mellitus	0.0017	0.00235	CcSEcCtD
Levorphanol—Flushing—Irbesartan—type 2 diabetes mellitus	0.00169	0.00233	CcSEcCtD
Levorphanol—Pruritus—Glipizide—type 2 diabetes mellitus	0.00168	0.00232	CcSEcCtD
Levorphanol—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00167	0.00231	CcSEcCtD
Levorphanol—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00165	0.00228	CcSEcCtD
Levorphanol—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00164	0.00227	CcSEcCtD
Levorphanol—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00163	0.00225	CcSEcCtD
Levorphanol—Palpitations—Valsartan—type 2 diabetes mellitus	0.00163	0.00225	CcSEcCtD
Levorphanol—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00163	0.00225	CcSEcCtD
Levorphanol—Muscle spasms—Metformin—type 2 diabetes mellitus	0.00161	0.00223	CcSEcCtD
Levorphanol—Palpitations—Orlistat—type 2 diabetes mellitus	0.00161	0.00222	CcSEcCtD
Levorphanol—Renal failure—Ramipril—type 2 diabetes mellitus	0.00161	0.00222	CcSEcCtD
Levorphanol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00161	0.00222	CcSEcCtD
Levorphanol—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00161	0.00222	CcSEcCtD
Levorphanol—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.0016	0.00221	CcSEcCtD
Levorphanol—Flushing—Losartan—type 2 diabetes mellitus	0.00159	0.0022	CcSEcCtD
Levorphanol—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00158	0.00219	CcSEcCtD
Levorphanol—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00158	0.00219	CcSEcCtD
Levorphanol—Convulsion—Orlistat—type 2 diabetes mellitus	0.00158	0.00218	CcSEcCtD
Levorphanol—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00158	0.00218	CcSEcCtD
Levorphanol—Dihydrocodeine—CYP3A4—type 2 diabetes mellitus	0.00158	0.0957	CrCbGaD
Levorphanol—Sweating—Ramipril—type 2 diabetes mellitus	0.00157	0.00217	CcSEcCtD
Levorphanol—Dizziness—Glipizide—type 2 diabetes mellitus	0.00157	0.00217	CcSEcCtD
Levorphanol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00156	0.00216	CcSEcCtD
Levorphanol—Tension—Irbesartan—type 2 diabetes mellitus	0.00155	0.00215	CcSEcCtD
Levorphanol—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00154	0.00213	CcSEcCtD
Levorphanol—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00154	0.00212	CcSEcCtD
Levorphanol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00153	0.00211	CcSEcCtD
Levorphanol—Arrhythmia—Losartan—type 2 diabetes mellitus	0.00153	0.00211	CcSEcCtD
Levorphanol—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00152	0.0021	CcSEcCtD
Levorphanol—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00152	0.0021	CcSEcCtD
Levorphanol—Estradiol—SHBG—type 2 diabetes mellitus	0.00151	0.0915	CrCbGaD
Levorphanol—Vomiting—Glipizide—type 2 diabetes mellitus	0.00151	0.00208	CcSEcCtD
Levorphanol—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.0015	0.00208	CcSEcCtD
Levorphanol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.0015	0.00207	CcSEcCtD
Levorphanol—Rash—Glipizide—type 2 diabetes mellitus	0.00149	0.00206	CcSEcCtD
Levorphanol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00149	0.00206	CcSEcCtD
Levorphanol—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00149	0.00206	CcSEcCtD
Levorphanol—Palpitations—Metformin—type 2 diabetes mellitus	0.00148	0.00205	CcSEcCtD
Levorphanol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00148	0.00205	CcSEcCtD
Levorphanol—Shock—Valsartan—type 2 diabetes mellitus	0.00148	0.00205	CcSEcCtD
Levorphanol—Tension—Losartan—type 2 diabetes mellitus	0.00146	0.00202	CcSEcCtD
Levorphanol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00146	0.00202	CcSEcCtD
Levorphanol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00146	0.00201	CcSEcCtD
Levorphanol—Agitation—Irbesartan—type 2 diabetes mellitus	0.00146	0.00201	CcSEcCtD
Levorphanol—Urticaria—Glyburide—type 2 diabetes mellitus	0.00145	0.002	CcSEcCtD
Levorphanol—Nervousness—Losartan—type 2 diabetes mellitus	0.00145	0.002	CcSEcCtD
Levorphanol—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00144	0.00199	CcSEcCtD
Levorphanol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00144	0.00199	CcSEcCtD
Levorphanol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00144	0.00199	CcSEcCtD
Levorphanol—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00143	0.00198	CcSEcCtD
Levorphanol—Visual impairment—Ramipril—type 2 diabetes mellitus	0.00142	0.00196	CcSEcCtD
Levorphanol—Nausea—Glipizide—type 2 diabetes mellitus	0.00141	0.00195	CcSEcCtD
Levorphanol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00141	0.00194	CcSEcCtD
Levorphanol—Hypotension—Valsartan—type 2 diabetes mellitus	0.00141	0.00194	CcSEcCtD
Levorphanol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.0014	0.00194	CcSEcCtD
Levorphanol—Constipation—Gliclazide—type 2 diabetes mellitus	0.0014	0.00194	CcSEcCtD
Levorphanol—Rash—Glimepiride—type 2 diabetes mellitus	0.00139	0.00193	CcSEcCtD
Levorphanol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00139	0.00193	CcSEcCtD
Levorphanol—Rash—Sitagliptin—type 2 diabetes mellitus	0.00139	0.00192	CcSEcCtD
Levorphanol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00139	0.00192	CcSEcCtD
Levorphanol—Agitation—Losartan—type 2 diabetes mellitus	0.00137	0.00189	CcSEcCtD
Levorphanol—Flushing—Ramipril—type 2 diabetes mellitus	0.00136	0.00188	CcSEcCtD
Levorphanol—Insomnia—Valsartan—type 2 diabetes mellitus	0.00136	0.00188	CcSEcCtD
Levorphanol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00135	0.00186	CcSEcCtD
Levorphanol—Shock—Metformin—type 2 diabetes mellitus	0.00135	0.00186	CcSEcCtD
Levorphanol—Insomnia—Orlistat—type 2 diabetes mellitus	0.00134	0.00186	CcSEcCtD
Levorphanol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00134	0.00185	CcSEcCtD
Levorphanol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00132	0.00183	CcSEcCtD
Levorphanol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00132	0.00183	CcSEcCtD
Levorphanol—Estradiol—AR—type 2 diabetes mellitus	0.00132	0.0803	CrCbGaD
Levorphanol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00132	0.00182	CcSEcCtD
Levorphanol—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00132	0.00182	CcSEcCtD
Levorphanol—Palpitations—Losartan—type 2 diabetes mellitus	0.00132	0.00182	CcSEcCtD
Levorphanol—Nausea—Glimepiride—type 2 diabetes mellitus	0.00131	0.00182	CcSEcCtD
Levorphanol—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00131	0.00181	CcSEcCtD
Levorphanol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00131	0.00181	CcSEcCtD
Levorphanol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00131	0.00181	CcSEcCtD
Levorphanol—Urticaria—Gliclazide—type 2 diabetes mellitus	0.0013	0.0018	CcSEcCtD
Levorphanol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00129	0.00179	CcSEcCtD
Levorphanol—Pruritus—Glyburide—type 2 diabetes mellitus	0.00129	0.00178	CcSEcCtD
Levorphanol—Constipation—Valsartan—type 2 diabetes mellitus	0.00129	0.00178	CcSEcCtD
Levorphanol—Hypotension—Metformin—type 2 diabetes mellitus	0.00128	0.00177	CcSEcCtD
Levorphanol—Shock—Irbesartan—type 2 diabetes mellitus	0.00127	0.00176	CcSEcCtD
Levorphanol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00127	0.00175	CcSEcCtD
Levorphanol—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00126	0.00174	CcSEcCtD
Levorphanol—Rash—Bromocriptine—type 2 diabetes mellitus	0.00126	0.00174	CcSEcCtD
Levorphanol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00126	0.00174	CcSEcCtD
Levorphanol—Tension—Ramipril—type 2 diabetes mellitus	0.00125	0.00173	CcSEcCtD
Levorphanol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00125	0.00173	CcSEcCtD
Levorphanol—Nervousness—Ramipril—type 2 diabetes mellitus	0.00124	0.00172	CcSEcCtD
Levorphanol—Dry mouth—Losartan—type 2 diabetes mellitus	0.00124	0.00172	CcSEcCtD
Levorphanol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00123	0.0017	CcSEcCtD
Levorphanol—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00123	0.0017	CcSEcCtD
Levorphanol—Confusional state—Losartan—type 2 diabetes mellitus	0.00123	0.0017	CcSEcCtD
Levorphanol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00123	0.00169	CcSEcCtD
Levorphanol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00122	0.00168	CcSEcCtD
Levorphanol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00121	0.00167	CcSEcCtD
Levorphanol—Hydrocodone—CYP3A4—type 2 diabetes mellitus	0.00121	0.0733	CrCbGaD
Levorphanol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00121	0.00167	CcSEcCtD
Levorphanol—Shock—Losartan—type 2 diabetes mellitus	0.0012	0.00165	CcSEcCtD
Levorphanol—Urticaria—Valsartan—type 2 diabetes mellitus	0.0012	0.00165	CcSEcCtD
Levorphanol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00119	0.00164	CcSEcCtD
Levorphanol—Tachycardia—Losartan—type 2 diabetes mellitus	0.00119	0.00164	CcSEcCtD
Levorphanol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00119	0.00164	CcSEcCtD
Levorphanol—Urticaria—Orlistat—type 2 diabetes mellitus	0.00118	0.00163	CcSEcCtD
Levorphanol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00118	0.00163	CcSEcCtD
Levorphanol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00118	0.00162	CcSEcCtD
Levorphanol—Agitation—Ramipril—type 2 diabetes mellitus	0.00117	0.00162	CcSEcCtD
Levorphanol—Constipation—Metformin—type 2 diabetes mellitus	0.00117	0.00162	CcSEcCtD
Levorphanol—Vomiting—Glyburide—type 2 diabetes mellitus	0.00116	0.0016	CcSEcCtD
Levorphanol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00116	0.0016	CcSEcCtD
Levorphanol—Rash—Glyburide—type 2 diabetes mellitus	0.00115	0.00159	CcSEcCtD
Levorphanol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00115	0.00159	CcSEcCtD
Levorphanol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00114	0.00157	CcSEcCtD
Levorphanol—Hypotension—Losartan—type 2 diabetes mellitus	0.00114	0.00157	CcSEcCtD
Levorphanol—Dextromethorphan—CYP2E1—type 2 diabetes mellitus	0.00113	0.0689	CrCbGaD
Levorphanol—Palpitations—Ramipril—type 2 diabetes mellitus	0.00113	0.00156	CcSEcCtD
Levorphanol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00113	0.00156	CcSEcCtD
Levorphanol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00112	0.00155	CcSEcCtD
Levorphanol—Convulsion—Ramipril—type 2 diabetes mellitus	0.00111	0.00153	CcSEcCtD
Levorphanol—Constipation—Irbesartan—type 2 diabetes mellitus	0.00111	0.00153	CcSEcCtD
Levorphanol—Insomnia—Losartan—type 2 diabetes mellitus	0.0011	0.00152	CcSEcCtD
Levorphanol—Estrone—CYP2E1—type 2 diabetes mellitus	0.00109	0.0661	CrCbGaD
Levorphanol—Urticaria—Metformin—type 2 diabetes mellitus	0.00109	0.0015	CcSEcCtD
Levorphanol—Nausea—Glyburide—type 2 diabetes mellitus	0.00108	0.0015	CcSEcCtD
Levorphanol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00108	0.0015	CcSEcCtD
Levorphanol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00108	0.0015	CcSEcCtD
Levorphanol—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00107	0.00148	CcSEcCtD
Levorphanol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00107	0.00147	CcSEcCtD
Levorphanol—Pruritus—Valsartan—type 2 diabetes mellitus	0.00106	0.00147	CcSEcCtD
Levorphanol—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00106	0.00147	CcSEcCtD
Levorphanol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00106	0.00146	CcSEcCtD
Levorphanol—Confusional state—Ramipril—type 2 diabetes mellitus	0.00105	0.00145	CcSEcCtD
Levorphanol—Pruritus—Orlistat—type 2 diabetes mellitus	0.00105	0.00145	CcSEcCtD
Levorphanol—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00104	0.00144	CcSEcCtD
Levorphanol—Constipation—Losartan—type 2 diabetes mellitus	0.00104	0.00144	CcSEcCtD
Levorphanol—Estrone—CYP1A2—type 2 diabetes mellitus	0.00104	0.0629	CrCbGaD
Levorphanol—Rash—Gliclazide—type 2 diabetes mellitus	0.00103	0.00143	CcSEcCtD
Levorphanol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00103	0.00143	CcSEcCtD
Levorphanol—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00103	0.00142	CcSEcCtD
Levorphanol—Shock—Ramipril—type 2 diabetes mellitus	0.00103	0.00142	CcSEcCtD
Levorphanol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00102	0.00141	CcSEcCtD
Levorphanol—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00102	0.00141	CcSEcCtD
Levorphanol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00101	0.00139	CcSEcCtD
Levorphanol—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.001	0.00139	CcSEcCtD
Levorphanol—Hydromorphone—CYP3A4—type 2 diabetes mellitus	0.001	0.0608	CrCbGaD
Levorphanol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000995	0.00138	CcSEcCtD
Levorphanol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000995	0.00137	CcSEcCtD
Levorphanol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000983	0.00136	CcSEcCtD
Levorphanol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000975	0.00135	CcSEcCtD
Levorphanol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000973	0.00134	CcSEcCtD
Levorphanol—Pruritus—Metformin—type 2 diabetes mellitus	0.000969	0.00134	CcSEcCtD
Levorphanol—Urticaria—Losartan—type 2 diabetes mellitus	0.000967	0.00134	CcSEcCtD
Levorphanol—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000962	0.00133	CcSEcCtD
Levorphanol—Vomiting—Valsartan—type 2 diabetes mellitus	0.000957	0.00132	CcSEcCtD
Levorphanol—Rash—Valsartan—type 2 diabetes mellitus	0.000949	0.00131	CcSEcCtD
Levorphanol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000948	0.00131	CcSEcCtD
Levorphanol—Vomiting—Orlistat—type 2 diabetes mellitus	0.000945	0.00131	CcSEcCtD
Levorphanol—Insomnia—Ramipril—type 2 diabetes mellitus	0.000944	0.0013	CcSEcCtD
Levorphanol—Rash—Orlistat—type 2 diabetes mellitus	0.000937	0.0013	CcSEcCtD
Levorphanol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000937	0.00129	CcSEcCtD
Levorphanol—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000918	0.00127	CcSEcCtD
Levorphanol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000915	0.00126	CcSEcCtD
Levorphanol—Dizziness—Metformin—type 2 diabetes mellitus	0.000906	0.00125	CcSEcCtD
Levorphanol—Nausea—Valsartan—type 2 diabetes mellitus	0.000894	0.00124	CcSEcCtD
Levorphanol—Constipation—Ramipril—type 2 diabetes mellitus	0.000892	0.00123	CcSEcCtD
Levorphanol—Nausea—Orlistat—type 2 diabetes mellitus	0.000883	0.00122	CcSEcCtD
Levorphanol—Vomiting—Metformin—type 2 diabetes mellitus	0.000871	0.0012	CcSEcCtD
Levorphanol—Rash—Metformin—type 2 diabetes mellitus	0.000864	0.00119	CcSEcCtD
Levorphanol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000863	0.00119	CcSEcCtD
Levorphanol—Pruritus—Losartan—type 2 diabetes mellitus	0.000861	0.00119	CcSEcCtD
Levorphanol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00086	0.00119	CcSEcCtD
Levorphanol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000855	0.00118	CcSEcCtD
Levorphanol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000853	0.00118	CcSEcCtD
Levorphanol—Morphine—CYP3A4—type 2 diabetes mellitus	0.000851	0.0517	CrCbGaD
Levorphanol—Urticaria—Ramipril—type 2 diabetes mellitus	0.000829	0.00115	CcSEcCtD
Levorphanol—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000825	0.00114	CcSEcCtD
Levorphanol—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000822	0.00114	CcSEcCtD
Levorphanol—Rash—Irbesartan—type 2 diabetes mellitus	0.000815	0.00113	CcSEcCtD
Levorphanol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000815	0.00113	CcSEcCtD
Levorphanol—Nausea—Metformin—type 2 diabetes mellitus	0.000814	0.00112	CcSEcCtD
Levorphanol—Dizziness—Losartan—type 2 diabetes mellitus	0.000805	0.00111	CcSEcCtD
Levorphanol—Estradiol—CYP1A2—type 2 diabetes mellitus	0.000785	0.0477	CrCbGaD
Levorphanol—Vomiting—Losartan—type 2 diabetes mellitus	0.000774	0.00107	CcSEcCtD
Levorphanol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000768	0.00106	CcSEcCtD
Levorphanol—Rash—Losartan—type 2 diabetes mellitus	0.000767	0.00106	CcSEcCtD
Levorphanol—Dermatitis—Losartan—type 2 diabetes mellitus	0.000767	0.00106	CcSEcCtD
Levorphanol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000738	0.00102	CcSEcCtD
Levorphanol—Nausea—Losartan—type 2 diabetes mellitus	0.000723	0.000999	CcSEcCtD
Levorphanol—Dextromethorphan—CYP3A4—type 2 diabetes mellitus	0.000714	0.0434	CrCbGaD
Levorphanol—Dizziness—Ramipril—type 2 diabetes mellitus	0.00069	0.000954	CcSEcCtD
Levorphanol—Estrone—CYP3A4—type 2 diabetes mellitus	0.000686	0.0416	CrCbGaD
Levorphanol—Vomiting—Ramipril—type 2 diabetes mellitus	0.000663	0.000917	CcSEcCtD
Levorphanol—Rash—Ramipril—type 2 diabetes mellitus	0.000658	0.000909	CcSEcCtD
Levorphanol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000657	0.000908	CcSEcCtD
Levorphanol—Nausea—Ramipril—type 2 diabetes mellitus	0.00062	0.000856	CcSEcCtD
Levorphanol—Estrone—ALB—type 2 diabetes mellitus	0.000598	0.0363	CrCbGaD
Levorphanol—Estradiol—CYP3A4—type 2 diabetes mellitus	0.00052	0.0316	CrCbGaD
Levorphanol—Estradiol—ALB—type 2 diabetes mellitus	0.000453	0.0275	CrCbGaD
Levorphanol—OPRD1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000153	0.000589	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000153	0.000588	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000153	0.000587	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000152	0.000586	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000152	0.000585	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000152	0.000584	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000151	0.000581	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.00015	0.000576	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000147	0.000565	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000147	0.000565	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000146	0.000563	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000146	0.000561	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000145	0.000559	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000145	0.000556	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000144	0.000553	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000141	0.000544	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000141	0.000544	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000141	0.000543	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000141	0.000543	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.00014	0.000537	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000139	0.000535	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000138	0.000531	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000137	0.000528	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000137	0.000528	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000137	0.000526	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000137	0.000526	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000137	0.000526	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000136	0.000524	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000135	0.000521	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000134	0.000517	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000134	0.000517	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000134	0.000517	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000134	0.000517	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000134	0.000515	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000134	0.000515	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000134	0.000515	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000134	0.000515	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000133	0.000512	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000132	0.000509	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000132	0.000509	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000131	0.000505	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000131	0.000503	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000131	0.000503	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000131	0.000502	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000131	0.000502	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.00013	0.0005	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000129	0.000495	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000128	0.000494	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000128	0.000494	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000127	0.000491	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000124	0.000479	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000124	0.000478	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000124	0.000477	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000124	0.000477	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000124	0.000476	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000124	0.000476	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000122	0.000471	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000122	0.000471	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000122	0.00047	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000122	0.000469	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.00012	0.000463	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.00012	0.000463	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.00012	0.000462	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.00012	0.000461	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.00012	0.000461	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000119	0.00046	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000118	0.000454	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000118	0.000453	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000117	0.000451	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000117	0.000451	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000117	0.000449	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000116	0.000446	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000116	0.000446	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000115	0.000443	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000115	0.000441	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000113	0.000437	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000113	0.000435	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000113	0.000435	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000113	0.000434	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000113	0.000433	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000113	0.000433	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000112	0.000433	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000111	0.000427	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000109	0.00042	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000109	0.000418	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000108	0.000417	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000108	0.000415	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000107	0.000413	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000107	0.000413	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000106	0.00041	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000106	0.000406	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000105	0.000406	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000105	0.000405	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000105	0.000403	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000105	0.000402	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000105	0.000402	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000104	0.0004	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000104	0.0004	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000104	0.000399	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000103	0.000397	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000103	0.000397	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000102	0.000393	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000102	0.000392	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000101	0.00039	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000101	0.00039	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000101	0.000387	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.0001	0.000386	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.0001	0.000385	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.96e-05	0.000383	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.92e-05	0.000382	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.92e-05	0.000382	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.9e-05	0.000381	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	9.87e-05	0.00038	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	9.86e-05	0.000379	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.79e-05	0.000377	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LPL—type 2 diabetes mellitus	9.6e-05	0.000369	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.52e-05	0.000366	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.4e-05	0.000362	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.33e-05	0.000359	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.25e-05	0.000356	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.22e-05	0.000355	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.18e-05	0.000353	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AVP—type 2 diabetes mellitus	9.12e-05	0.000351	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.12e-05	0.000351	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.08e-05	0.00035	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	9.07e-05	0.000349	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.07e-05	0.000349	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.04e-05	0.000348	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.01e-05	0.000347	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.95e-05	0.000344	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.92e-05	0.000343	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.89e-05	0.000342	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.85e-05	0.00034	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOB—type 2 diabetes mellitus	8.82e-05	0.000339	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.78e-05	0.000338	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.68e-05	0.000334	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—C3—type 2 diabetes mellitus	8.65e-05	0.000333	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.49e-05	0.000327	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LPL—type 2 diabetes mellitus	8.42e-05	0.000324	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.34e-05	0.000321	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.33e-05	0.000321	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.25e-05	0.000317	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.24e-05	0.000317	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.22e-05	0.000316	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.21e-05	0.000316	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.08e-05	0.000311	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.05e-05	0.00031	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.05e-05	0.00031	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.96e-05	0.000306	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.9e-05	0.000304	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.89e-05	0.000304	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.82e-05	0.000301	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.76e-05	0.000299	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	7.71e-05	0.000297	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.71e-05	0.000297	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.68e-05	0.000295	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.64e-05	0.000294	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.59e-05	0.000292	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—C3—type 2 diabetes mellitus	7.58e-05	0.000292	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.56e-05	0.000291	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	7.45e-05	0.000287	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.42e-05	0.000286	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.33e-05	0.000282	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.23e-05	0.000278	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.21e-05	0.000278	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGT—type 2 diabetes mellitus	7.2e-05	0.000277	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.18e-05	0.000276	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.12e-05	0.000274	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.08e-05	0.000273	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.06e-05	0.000272	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.06e-05	0.000272	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.98e-05	0.000268	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.97e-05	0.000268	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—INS—type 2 diabetes mellitus	6.88e-05	0.000265	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.77e-05	0.00026	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.68e-05	0.000257	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.66e-05	0.000256	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.65e-05	0.000256	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.65e-05	0.000256	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.62e-05	0.000255	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.56e-05	0.000252	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	6.41e-05	0.000247	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.32e-05	0.000243	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.3e-05	0.000242	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.11e-05	0.000235	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.1e-05	0.000235	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.09e-05	0.000234	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.03e-05	0.000232	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.03e-05	0.000232	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	6.03e-05	0.000232	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.99e-05	0.00023	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.97e-05	0.00023	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.97e-05	0.00023	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.93e-05	0.000228	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.9e-05	0.000227	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.83e-05	0.000224	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.83e-05	0.000224	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.8e-05	0.000223	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.68e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.63e-05	0.000216	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.54e-05	0.000213	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.32e-05	0.000205	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.29e-05	0.000203	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.29e-05	0.000203	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.17e-05	0.000199	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.12e-05	0.000197	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	5.1e-05	0.000196	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.09e-05	0.000196	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.01e-05	0.000193	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.98e-05	0.000192	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.93e-05	0.00019	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.93e-05	0.00019	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.9e-05	0.000189	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.84e-05	0.000186	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.79e-05	0.000184	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.69e-05	0.000181	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.68e-05	0.00018	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.53e-05	0.000174	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.49e-05	0.000173	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.47e-05	0.000172	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.47e-05	0.000172	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.46e-05	0.000172	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.46e-05	0.000172	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.34e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.24e-05	0.000163	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.21e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.2e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.11e-05	0.000158	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.99e-05	0.000153	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.91e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.91e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.83e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.81e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.79e-05	0.000146	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.77e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.59e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.55e-05	0.000136	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.5e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.48e-05	0.000134	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.43e-05	0.000132	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.31e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.22e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	3e-05	0.000116	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.95e-05	0.000114	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.9e-05	0.000111	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.77e-05	0.000107	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.63e-05	0.000101	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.43e-05	9.35e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.23e-05	8.57e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.05e-05	7.9e-05	CbGpPWpGaD
